Spermidine Supplements Market to Reach $1.2 Billion by 2030 with 9.8% CAGR
The global Spermidine Supplements market is gaining rapid traction due to growing scientific evidence linking spermidine to cellular regeneration and longevity. Valued at $520 million in 2022, the market is projected to reach $1.2 billion by 2030, expanding at a CAGR of 9.8% from 2023 to 2030. Rising consumer focus on anti-aging, autophagy, and preventive health is significantly boosting...
0 Comments 0 Shares 95 Views 0 Reviews